Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Clinical trial NCT00460486 · COMPLETED

Trial details

NCT number: NCT00460486
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Encephalitis, Tick-Borne

Start date: 2006-09-01
Primary completion: 2007-11-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.